Lineage Cell Therapeutics, Inc.

NYSE American: LCTX
Share price (12/26/25): $1.65
Market cap (12/26/25): $380 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

ended 12/31/24 FY 2024

ended 09/30/24 Q3

Prospectuses and Registrations Filter

Prospectus supplement

Registration of securities for employees

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Ownership Filter

Samuel George A. III

Broadwood Partners, L.P.

News Filter

Reports Third Quarter 2025 Financial Results and Provides Business Update

Material Disclosure, Other Events, Financial Statements or Exhibits

Proxies Filter

Additional info about upcoming vote

Additional info about upcoming vote

Definitive proxy

Definitive proxy

Preliminary proxy

Other Filter

Scanned paper annual report submission

Notice of effectiveness

Scanned paper annual report submission

Scanned paper annual report submission

Notice of effectiveness